Innovations, Social and Economic Megatrends to understand the World of Tomorrow.

Can I have a in-depth study on the current state of the Gastrointestinal OTC Drugs industry?

Good day,

Thank you for contacting ReportLinker.  Out of our many reports about the OTC drugs market, we have selected three to help you with your question.

The first report, titled Global Gastrointestinal OTC Drugs Industry Report 2015 was published by QY Research Group in July 2015.  This 206 page study looks at the current state of the industry, providing an overview with backgrounds on the definitions, classifications, applications and the industry chain structure.  This report investigates the trends, competitive landscape and the key regions.  The manufacturing processes and cost structures are looked at along with the development policies and plans.  Import and export consumption, supply and demand, cost, price, revenue and gross margins are all looked at.  Profiles of the key industry players feature information on their products and specifications, capacity, production, price, cost, revenue and contact information.  There is also an analysis on the development trends and marketing channels.  New investment projects are assessed for their viability and overall conclusions are given in this report.

The next 101 page report, Global Gastrointestinal OTC Drugs Market 2015-2019, was published by Infiniti Research Limited in April 2015.  It looks at the current situation of the market and provides forecasts for the 2014-2019 period.  This report looks at the market size, growth trends and main drivers.  The data for this report was collected by looking at the sales of some over-the-counter drugs used to manage disorders such as GERD or heartburn, constipation, diarrhea, nausea due to motion sickness and flatulence.  The key regions looked at in the report are the Americas, Asia Pacific and Europe, the Middle East and Asia.  The leading players are Bayer, GlaxoSmtihKline, Johnson & Johnson, Perrigo, Pfizer and Procter & Gamble.  The market is expected to have a compound annual growth rate of 1.48% from 2014-2019.

We hope this information has been helpful to you.  There is a lot of useful information about the pharmaceutical industry in ReportLinker’s portal.  If you have any questions or further needs, please feel free to contact us.